techcrunch.com·Apr 15, 2026
Aloe Blacc, after contracting COVID despite being vaccinated, attempted to fund biotech research but discovered that financial contributions alone are insufficient due to regulatory requirements. He is now developing a cancer drug platform focused on pancreatic cancer.
The content highlights that in biotech, it's not sufficient to simply fund research; a comprehensive commercialization plan is essential to navigate regulatory requirements and move science through clinical trials successfully. This underscores the importance for healthtech professionals to understand the business and regulatory landscape, including the intricacies of IP licensing and the role of philanthropy, when pursuing innovations in drug development.